MedTrace Logo

Ultrasound and Endometrial Hyperplasia

NCT00123188 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2015-01-19

No results posted yet for this study

Summary

The investigators hypothesize that endometrial thickness will be a significant predictor of endometrial hyperplasia in a postmenopausal female population with metabolic syndrome: diabetes and/or insulin resistance, hypertension, and obesity.

Conditions

  • Endometrial Hyperplasia

Interventions

PROCEDURE

Ultrasound and Biopsy

Transvaginal ultrasound and Endometrial Biopsy

Sponsors & Collaborators

  • Center for Research on Women and Health

    collaborator UNKNOWN

  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • Richard Legro, M.D. · Penn State College of Medicine

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00123188 on ClinicalTrials.gov